Mike Fisher PhD brings business development boost to BioPartner UK Advisory Board
Published on 30/10/2024
BioPartner UK, the leading biotechnology business development organisation, is delighted to announce the appointment of Mike Fisher, PhD, VP and Head of Business Development at Oncimmune, to its Advisory Board. BioPartner UK’s Advisory Board is representative of the membership: globally focused examples of UK expertise including senior investors, executive and non-executive directors, and business development executives.
BioPartner strives to raise awareness of global opportunities for small-to-medium enterprises and start-ups, while promoting membership and maximising value for its members. Mike is a Life Sciences professional with 25+ years’ experience in research, project management and business development. In his current role at Oncimmune, he leads the global commercial team, driving the company’s international growth.
He also serves as VP at the British American Business Council (BABCNE) based in Massachusetts, USA. Mike previously worked in business development roles at two UK startup companies and prior to this, he worked with UK non-profit agencies and government international relations. Upon his appointment, Mike said, “I am thrilled to join BioPartner UK and be part of an independent organisation that is dedicated to supporting UK international trade. I am keen to leverage my experience to help unlock global business opportunities for our members.”
Lin Bateson, Chief Executive of BioPartner UK, also commented on Mike’s appointment, saying, "We are delighted to welcome Mike to our Advisory Board. His experience and global contacts make him an invaluable asset as we continue strengthening our position as a leading hub for biotechnology collaboration. We look forward to his contributions in ensuring the success of our upcoming activities.”